Detalhe da pesquisa
1.
Efficacy and safety of azacitidine in pediatric patients with newly diagnosed advanced myelodysplastic syndromes before hematopoietic stem cell transplantation in the AZA-JMML-001 trial.
Pediatr Blood Cancer
; 71(5): e30931, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38433307
2.
Results of a phase 2, multicenter, single-arm, open-label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia.
Pediatr Blood Cancer
; 68(7): e28946, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33694257
3.
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma.
Blood
; 128(4): 497-503, 2016 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27226434
4.
Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors.
Front Oncol
; 11: 660892, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34168987
5.
Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial.
Blood Adv
; 5(14): 2901-2908, 2021 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297046
6.
Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06).
Oncologist
; 15(3): 285-92, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20203173
7.
Oxaliplatin, irinotecan and capecitabine (OCX) for first-line treatment of advanced/metastatic colorectal cancer: a phase I trial (SAKK 41/03).
Onkologie
; 33(6): 295-9, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20523092
8.
Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network.
Eur J Cancer
; 135: 89-97, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32554315
9.
Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study.
Antivir Ther
; 13(8): 1077-82, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19195333
10.
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancer.
Eur J Cancer
; 100: 27-34, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29936064
11.
Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study.
Antivir Ther
; 12(8): 1165-73, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-18240857
12.
Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
Antivir Ther
; 12(6): 931-9, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17926647
13.
Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study.
BMC Infect Dis
; 7: 21, 2007 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-17386104
14.
Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer.
Cancer
; 117(15): 3532; author reply 3532-3, 2011 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21287542
15.
A smoking cessation programme in HIV-infected individuals: a pilot study.
Antivir Ther
; 11(6): 787-95, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17310823
16.
A longitudinal analysis of healthcare costs after treatment optimization following genotypic antiretroviral resistance testing: does resistance testing pay off?
Antivir Ther
; 11(3): 305-14, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16759046
17.
Clinical implications of distinct metastasizing preferences of different melanoma subtypes.
Eur J Dermatol
; 24(2): 236-41, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24721680
18.
Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98).
Haematologica
; 93(9): 1426-8, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18603561
19.
Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08).
Clin Lung Cancer
; 14(1): 34-9, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22633220
20.
Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94).
Radiother Oncol
; 104(2): 213-8, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22726581